首页> 美国卫生研究院文献>Drug Design Development and Therapy >Current progress in the development of a prophylactic vaccine for HIV-1
【2h】

Current progress in the development of a prophylactic vaccine for HIV-1

机译:HIV-1预防性疫苗开发的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since its discovery and characterization in the early 1980s as a virus that attacks the immune system, there has been some success for the treatment of human immunodeficiency virus-1 (HIV-1) infection. However, due to the overwhelming public health impact of this virus, a vaccine is needed urgently. Despite the tireless efforts of scientist and clinicians, there is still no safe and effective vaccine that provides sterilizing immunity. A vaccine that provides sterilizing immunity against HIV infection remains elusive in part due to the following reasons: 1) degree of diversity of the virus, 2) ability of the virus to evade the hosts’ immunity, and 3) lack of appropriate animal models in which to test vaccine candidates. There have been several attempts to stimulate the immune system to provide protection against HIV-infection. Here, we will discuss attempts that have been made to induce sterilizing immunity, including traditional vaccination attempts, induction of broadly neutralizing antibody production, DNA vaccines, and use of viral vectors. Some of these attempts show promise pending continued research efforts.
机译:自从其在1980年代初被发现并表征为攻击免疫系统的病毒以来,在治疗人类免疫缺陷病毒1(HIV-1)感染方面取得了一些成功。但是,由于该病毒对公众健康的巨大影响,因此迫切需要疫苗。尽管科学家和临床医生做出了不懈的努力,但仍没有安全有效的疫苗可以提供杀菌免疫。提供针对HIV感染的灭菌免疫力的疫苗仍然难以捉摸,部分原因如下:1)病毒的多样性程度; 2)病毒逃避宿主免疫力的能力; 3)缺乏适当的动物模型测试候选疫苗。已经进行了多种尝试来刺激免疫系统以提供针对HIV感染的保护。在这里,我们将讨论诱导灭菌免疫的尝试,包括传统的疫苗接种尝试,广泛中和抗体的诱导,DNA疫苗以及病毒载体的使用。这些尝试中的某些表明有希望继续进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号